nejm semaglutide cardiovascular and Outcomes in Patients with Type 2 Diabetes Cardiovascular outcomes of semaglutide and

Outliers detected in MR-PRESSO for overall and sex-specific associations of genetically predicted l-carnitine with CVD and CVD risk factors

Lexapro has a boxed warning , the most serious type of warning from the Food and Drug Administration (FDA)

BPC-157 Comparison to Related Research Compounds BPC-157 is frequently studied alongside other peptides that influence tissue repair signaling, angiogenic pathways, and cytoskeletal regulation in experimental models

Healthcare providers should consider alternative antifungal agents or routes of administration in patients requiring concurrent therapy

World Health Organization (2019)